<div id="readability-page-1"><div>Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In SelectQuote To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] <img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/3a3fa937-87cb-45e3-b706-966046064eee/ff-pressrelease-imagetemplate-080425.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="3126" height="1167" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/3a3fa937-87cb-45e3-b706-966046064eee/ff-pressrelease-imagetemplate-080425.png"/> NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) -- Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE:SLQT) and reminds investors of the October 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi &amp; Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that the Company was directing Medicare beneficiaries to the plans offered by insurers that best compensated SelectQuote, regardless of the quality or suitability of the insurers’ plans; (2) that SelectQuote did not provided unbiased comparison shopping for Medicare Advantage insurance plans; (3) that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers and limit enrollment in competitors’ plans; (4) that as a result, SelectQuote had not complied with applicable laws, regulations, and contractual provisions; (5) that SelectQuote was vulnerable to regulatory and legal sanctions as a result of its conduct, including claims that it had violated the False Claims Act; and (6) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On May 1, 2025, the U.S. Department of Justice (“DOJ”) filed a False Claims Act complaint against SelectQuote, alleging, “[f] rom 2016 through at least 2021” SelectQuote received “tens of millions of dollars” in “illegal kickbacks” from health insurance companies in exchange for steering Medicare beneficiaries to enroll in the insurers’ plans. Further, SelectQuote, in exchange for kickbacks, engaged in a conspiracy with major insurers to illegally discriminate against beneficiaries deemed to be less profitable, including those with disabilities. The DOJ concluded that SelectQuote made materially false claims by stating it offers “unbiased coverage comparisons” when in fact it “repeatedly directed Medicare beneficiaries to the plans offered by insurers that paid them the most money, regardless of the quality or suitability of the insurers’ plans.” On this news, SelectQuote’s stock price fell $0.61, or 19.2%, to close at $2.56 per share on May 1, 2025, on unusually heavy trading volume. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi &amp; Faruqi, LLP also encourages anyone with information regarding SelectQuote’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the SelectQuote class action, go to www.faruqilaw.com/SLQT or call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi &amp; Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3a3fa937-87cb-45e3-b706-966046064eee <img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVeE16VXhNeU0zTVRBeU5EQTVJekl3TVRjMk16WT0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVeE16VXhNeU0zTVRBeU5EQTVJekl3TVRjMk16WT0"/> <img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/OTZiMmRlNzItMjA1Mi00NTBiLTg5NDgtYjU0YTIxNjc5MGNiLTEwMjkyMDktMjAyNS0wOC0xNi1lbg==/tiny/Faruqi-Faruqi-LLP.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/OTZiMmRlNzItMjA1Mi00NTBiLTg5NDgtYjU0YTIxNjc5MGNiLTEwMjkyMDktMjAyNS0wOC0xNi1lbg==/tiny/Faruqi-Faruqi-LLP.png"/> <img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/8628babf-2ea4-4b8a-a60b-260db109bfa2/small/logo-png.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="150" height="81" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/8628babf-2ea4-4b8a-a60b-260db109bfa2/small/logo-png.png"/><h2>James (Josh) Wilson, Faruqi &amp; Faruqi Senior Partner</h2> <img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/3a3fa937-87cb-45e3-b706-966046064eee/medium/james-josh-wilson-faruqi-faruqi-senior-partner.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="300" height="112" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/3a3fa937-87cb-45e3-b706-966046064eee/medium/james-josh-wilson-faruqi-faruqi-senior-partner.png"/> <h2>James (Josh) Wilson, Faruqi &amp; Faruqi Senior Partner</h2></div></div>

SLQT

Faruqi & Faruqi, LLP is investigating claims on behalf of investors who suffered losses exceeding $75,000 in SelectQuote, Inc. between September 9, 2020, and May 1, 2025. The firm highlights a federal securities class action against SelectQuote, alleging violations of federal securities laws, including misleading statements and illegal kickbacks related to Medicare plans. The deadline to seek the role of lead plaintiff is October 10, 2025. Following the DOJ's complaint, SelectQuote's stock fell 19.2% on May 1, 2025. Investors are encouraged to contact the firm for more information.

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SelectQuote